Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T14:57:47.095Z.
Calculation as of: 2026-10-06T14:57:47.095Z.
Quote observation: 2026-10-06T14:55:25.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 53f0b653117dfddf80d57e74ba570551200adc0db5709ea8e1a3c029d43ac92d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
MBX Biosciences, Inc. Common Stock
Market Cap
$2.69B
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.69B
Free Cash Flow Yield
5.89%
TTM Avg
5.78%
3Y Avg
3.95%
5Y Avg
3.33%
Market Cap
$2.70B
Free Cash Flow Yield
N/A
TTM Avg
0.77%
3Y Avg
2.82%
5Y Avg
3.32%
Market Cap
$2.68B
Free Cash Flow Yield
N/A
TTM Avg
0.48%
3Y Avg
1.33%
5Y Avg
1.45%
Market Cap
$2.61B
Free Cash Flow Yield
N/A
TTM Avg
3.15%
3Y Avg
3.15%
5Y Avg
3.15%
Market Cap
$2.60B
Free Cash Flow Yield
N/A
TTM Avg
12.15%
3Y Avg
12.15%
5Y Avg
12.15%
Market Cap
$2.81B
Free Cash Flow Yield
2.81%
TTM Avg
3.13%
3Y Avg
2.70%
5Y Avg
2.70%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MBX Biosciences, Inc. Common Stock (MBX) | $2.69B | N/A | N/A | N/A | N/A |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 5.89% | 5.78% | 3.95% | 3.33% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.70B | N/A | 0.77% | 2.82% | 3.32% |
| Neogen Corporation (NEOG)vs › | $2.68B | N/A | 0.48% | 1.33% | 1.45% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.61B | N/A | 3.15% | 3.15% | 3.15% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.60B | N/A | 12.15% | 12.15% | 12.15% |
| AtriCure, Inc. (ATRC)vs › | $2.78B | 1.84% | 2.05% | 1.80% | 1.80% |
| TransMedics Group, Inc. (TMDX)vs › | $2.81B | 2.81% | 3.13% | 2.70% | 2.70% |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.87B | N/A | N/A | N/A | N/A |
| Disc Medicine, Inc. (IRON)vs › | $2.43B | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
